GAM
EXAS

Groupama Asset Management’s Exact Sciences EXAS Stock Holding History

Groupama Asset Management’s Portfolio EXAS Stock Details EXAS Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q1 		– Sell
-3,025
Closed -$307K – 418
2025
Q4 		$307K Buy
+3,025
New +$243K ﹤0.01% 396
2025
Q3 		– Sell
-10,236
Closed -$511K – 241
2025
Q2 		$1.7M Hold
10,236
– – 0.03% 211
2025
Q1 		$1.56M Buy
10,236
+1,090
+12% +$55.2K 0.03% 214
2024
Q4 		$1.63M Buy
9,146
+4,194
+85% +$261K 0.03% 220
2024
Q3 		$1.21M Buy
+4,952
New +$279K 0.03% 230

Other funds holding EXAS

VanEck Associates
VanEck Associates New York $164B AUM 112.45% 1-Year Est. Return
Wealth Enhancement Advisory Services
Wealth Enhancement Advisory Services Plymouth, Minnesota $59.8B AUM 29.42% 1-Year Est. Return
PRS
Pinkerton Retirement Specialists Coeur D Alene, Idaho $1.16B AUM 28.78% 1-Year Est. Return
PWMAG
Pinnacle Wealth Management Advisory Group Red Bank, New Jersey $1.68B AUM 31.18% 1-Year Est. Return
IA
IFP Advisors Tampa, Florida $5.54B AUM 27.43% 1-Year Est. Return
HNB
Huntington National Bank Columbus, Ohio $20.6B AUM 34.61% 1-Year Est. Return
BC
Broadwater Capital Boston, Massachusetts $138M AUM 28.86% 1-Year Est. Return

Groupama Asset Management's EXAS Position: Q1 2026 in Review

Groupama Asset Management sold out of Exact Sciences (EXAS) in Q1 2026, closing a stake of 3,025 shares — an estimated $307K sold.

Groupama Asset Management first reported a position in EXAS in Q3 2024 and held it in 5 quarters. The position peaked at $1.7M in Q2 2025. 7 funds tracked by Wall St. Rank hold EXAS as of Q1 2026.

  • Groupama Asset Management reported no remaining Exact Sciences position as of Q1 2026 after selling out during the quarter.
  • Groupama Asset Management sold 3,025 Exact Sciences shares in Q1 2026, an estimated $307K.
  • Groupama Asset Management first reported a position in Exact Sciences in Q3 2024 and held it in 5 quarters.
  • Groupama Asset Management's Exact Sciences position peaked at $1.7M in Q2 2025.
  • 7 funds tracked by Wall St. Rank held Exact Sciences as of Q1 2026.

Based on Groupama Asset Management's 13F filing for Q1 2026, filed 22 May 2026.